HMK Pharma Private Limited
About HMK Pharma Private Limited
Data last updated:
HMK Pharma Private Limited is a private limited company based in Kadapa, Andhra Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 05 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74999AP2018PTC108089. Its GSTIN is 37AAECH4981Q1ZR (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Venkata Paritala Subba Rao and Lakshmi Paritala Kalyani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 41/1470 Ground Floor Sanakarapuram Kadapa, Andhra Pradesh, India – 516001.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.76 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹50,888 (net margin 1.4%) and EBITDA of ₹71,798 (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 24% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address41/1470 Ground Floor Sanakarapuram Kadapa, Andhra Pradesh, India – 516001
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of HMK Pharma Private Limited
The main business activity of HMK Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of HMK Pharma Private Limited FY 2025 filings available
HMK Pharma Private Limited reported revenue of ₹35.76 Lakh (down 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of HMK Pharma Private Limited
Revenue fell 23% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of HMK Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71,798 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹50,888 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of HMK Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of HMK Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of HMK Pharma Private Limited
HMK Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Paritala Subba Rao | Director | 05 Apr 2018 | 8 Years 6 Months | Current |
| Lakshmi Paritala Kalyani | Director | 05 Apr 2018 | 8 Years 6 Months | Current |
Ownership and Shareholding of HMK Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of HMK Pharma Private Limited
HMK Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at HMK Pharma Private Limited
Employment history and EPFO contributions of people linked to HMK Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on HMK Pharma Private Limited
HMK Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Lakshmi Paritala Kalyani was appointed as Director on 05 Apr 2018.
Credit Ratings, Litigation & Regulatory Alerts for HMK Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by HMK Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of HMK Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of HMK Pharma Private Limited
HMK Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAECH4981Q1ZR | Andhra Pradesh | Active | 07 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of HMK Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HMK Pharma Private Limited
HMK Pharma is an active private limited company based in Kadapa, Andhra Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 05 April 2018 (8+ years old) and is registered under CIN U74999AP2018PTC108089.
HMK Pharma reported revenue of ₹35.76 Lakh for FY 2025 (down 23% YoY).
HMK Pharma has 2 current directors:
- Venkata Paritala Subba Rao - Director
- Lakshmi Paritala Kalyani - Director
HMK Pharma reported a net profit of ₹50,888 (net margin 1.4%) and EBITDA of ₹71,798 (EBITDA margin 2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of HMK Pharma is -7% over three years and 24% over five years. In the latest year (FY 2025) revenue fell 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of HMK Pharma is 37AAECH4981Q1ZR, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of HMK Pharma is U74999AP2018PTC108089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HMK Pharma was incorporated on 05 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Vijayawada.
Lakshmi Paritala Kalyani was appointed as Director on 05 Apr 2018. Venkata Paritala Subba Rao was appointed as Director on 05 Apr 2018.
The registered office of HMK Pharma is at 411470 Ground Floor Sanakarapuram Kadapa, Andhra Pradesh, India – 516001.